UNSPSC 51343405: Celgosivir hydrochloride

This classification denotes an enzyme inhibitor with the molecular formula C12H21NO5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70U2NQU0FP, chemically known as castanospermine, 6-o-butyrate hydrochloride but more generally known as celgosivir hydrochloride, which bears US NIH Compound Identifier 3033824. Most nations, for tariff and trade purposes, schedule celgosivir hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, CELGOSIVIR HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Celgosivir hydrochloride bears US NLM identifiers UMLS ID C2828312 and NCI Concept Code C87464. SMILES: CCCC(=O)O[C@H]1CN2CC[C@@H]([C@@H]2[C@H]([C@@H]1O)O)O.CL.

UNSPSC 51343405 Celgosivir hydrochloride, a Commodity code, shows a significant mismatch between its nominal scope and the recent state and local solicitations tagged under it. The code itself specifies a particular antiviral pharmaceutical compound, yet the four recent opportunities posted under this code do not include celgosivir hydrochloride or any direct pharmaceutical manufacturing or supply of that product. Instead, state and local buyers have tagged opportunities for naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing. This disconnect suggests that either the source data contains a tagging error or the UNSPSC 51343405 category has been applied inconsistently by issuing bodies to broader pharmaceutical procurement activity.

The issuing bodies driving recent activity under this code span multiple jurisdiction types: Seminole County, Florida (county health procurement); the Texas Health and Human Services Commission (state health agency conducting a Request for Information); the City of Tampa (municipal government with a fire-department supply need); and the Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration (cooperative vehicle serving state and local participants across multiple states including Oregon). Geographic concentration emerges in Florida, Texas, and Minnesota, with the MMCAP cooperative representing the broadest multi-state footprint. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems with a response deadline of July 26, 2023; the City of Tampa's invitation to bid for medical and first aid supplies (estimated at $700,000) due March 13, 2026, sheltered exclusively for certified Small Local Business Enterprises with a 5 percent bid discount; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, distributing through authorized wholesalers effective July 1, 2026. The code's actual procurement activity does not align with celgosivir hydrochloride supply or specification.